Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.
Journal: Pediatric hematology and oncology
Published: April 28, 2020
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Journal: The Lancet. Oncology
Published: November 06, 2017
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.
Journal: Pediatric blood & cancer
Published: October 31, 2014
Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity.
Journal: Pediatric blood & cancer
Published: August 17, 2012
Respiratory Tract Infections Due to Human Metapneumovirus in Immunocompromised Children.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: August 02, 2012
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Journal: Blood
Published: October 05, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026